Factors Associated with Serological Cure and the Serofast State of HIV-Negative Patients with Primary, Secondary, Latent, and Tertiary Syphilis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tong, Man Li ^a   Lin, Li Rong ^a   Liu, Gui Li ^a   Zhang, Hui Lin ^a   Zeng, Yan Li ^a   Zheng, Wei Hong ^a   Liu, Li Li ^a,b   Yang, Tian Ci ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; DOXYCYCLINE;

ADULT; AGE; ARTICLE; CHINA; COHORT ANALYSIS; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONTREPONEMAL ANTIBODY TEST; PRIMARY SYPHILIS; REAGIN TEST; SECONDARY SYPHILIS; SEROFAST STATE; SEROLOGICAL CURE; SEX DIFFERENCE; SYPHILIS; SYPHILIS SEROLOGY; TERTIARY SYPHILIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN MAPPING; CASE-CONTROL STUDIES; CELL PHYSIOLOGICAL PHENOMENA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; MICE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURAL NETWORKS (COMPUTER); NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 84880716864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070102     Document Type: Article

References (38)

1. Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, et al. (2012) Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. J Neurol Sci 317: 35-39.
2. Ghanem KG, Workowski KA, (2011) Management of Adult Syphilis. Clin Infect Dis 53: S110-S128.
3. Dowell D, Polgreen PM, Beekmann SE, Workowski KA, Berman SM, et al. (2009) Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis 49: 1526.
4. WHO (2011) Global HIV/AIDS response: Epidemic update and health sector progress towards universal access: Progress report. Geneva, Switzerland: World Health Organization.
5. Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, et al. (2007) Syphilis in China: results of a national surveillance programme. The Lancet 369: 132-138.
6. Rothschild BM, (2005) History of syphilis. Clin Infect Dis 40: 1454-1463.
7. Workowski KA, Berman SM, (2010) Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 59: 1-110.
8. Moore JE, Padget P, (1938) The problem of seroresistant syphilis. Journal of the American Medical Association 110: 96-100.
9. Tsang RSW, Martin IE, Lau A, Sawatzky P, (2007) Serological diagnosis of syphilis: comparison of the Trep-Chek IgG enzyme immunoassay with other screening and confirmatory tests. FEMS Immunol Med Microbiol 51: 118-124.
10. Rolfs RT, Joesoef R, Hendershot EF, Rompalo AM, Augenbraun MH, et al. (1997) A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 337: 307-314.
11. Lin L-R, Zheng W-H, Tong M-L, Fu Z-G, Liu G-L, et al. (2011) Further Evaluation of the Characteristics of Treponema Pallidum-specific IgM antibody in syphilis serofast reaction patients. Diagnostic Microbiology and Infectious Disease 71: 201-207.
12. Lin LR, Tong ML, Fu ZG, Dan B, Zheng WH, et al. (2011) Evaluation of a colloidal gold immunochromatography assay in the detection of Treponema pallidum specific IgM antibody in syphilis serofast reaction patients: a serologic marker for the relapse and infection of syphilis. Diagn Microbiol Infect Dis 70: 10-16.
13. Workowski KA, Berman SM, (2006) Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 55: 1-94.
14. Higuchi K, Urabe H, Yoshida M, (1961) Some problems on seroresistant syphilis. Kyushu J Med Sci 12: 283-299.
15. Seña AC, Wolff M, Martin DH, Behets F, Van Damme K, et al. (2011) Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 53: 1092-1099.
16. CDC (1998) 1998 guidelines for treatment of sexually transmitted diseases. MMWR Recomm Rep 1998 47: 1-111.
17. French P, Gomberg M, Janier M, Schmidt B, van Voorst Vader P, et al. (2009) IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS 20: 300-309.
18. Aldave AJ, King JA, Cunningham Jr ET, (2001) Ocular syphilis. Curr Opin Ophthalmol 12: 433-441.
19. Ghanem K, Erbelding E, Wiener Z, Rompalo A, (2007) Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 83: 97.
20. Yinnon AM, Coury-Doniger P, Polito R, Reichman RC, (1996) Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 156: 321.
21. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ, (1991) Serologic response to treatment of infectious syphilis. Ann Intern Med 114: 1005-1009.
22. Brown ST, Zaidi A, Larsen SA, Reynolds GH, (1985) Serological response to syphilis treatment. JAMA: the journal of the American Medical Association 253: 1296-1299.
23. Chen J, (2004) Update on emerging infections: news from the Centers for Disease Control and Prevention. Brief report: azithromycin treatment failures in syphilis infections-San Francisco, California, 2002-2003. Ann Emerg Med 44: 232.
24. Serragui S, Yahyaoui M, Hassar M, Chkili T, Bouhaddioui N, et al. (1999) A comparison study of two therapeutic protocols for neurosyphilis. Therapie 54: 613-621.
25. Li SL LZ, Zhang HS, et al. (2012) Relationship between syphilis serofast reaction and neurosyphilis. Chin J Nosocomiol 20: 2235-2238.
26. Salazar JC, Hazlett KRO, Radolf JD, (2002) The immune response to infection with Treponema pallidum, the stealth pathogen. Microbes and infection 4: 1133-1140.
27. Hahn RA, Magder LS, Aral SO, Johnson RE, Larsen SA, (1989) Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic study. Am J Public Health 79: 467-470.
28. Lahita R, (2000) Gender and the immune system. The journal of gender-specific medicine: JGSM: the official journal of the Partnership for Women's Health at Columbia 3: 19.
29. Horberg MA, Ranatunga DK, Quesenberry CP, Klein DB, Silverberg MJ, (2010) Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California. Sex Transm Dis 37: 53.
30. Baker-Zander SA, Shaffer JM, Lukehart SA, (1993) VDRL antibodies enhance phagocytosis of Treponema pallidum by macrophages. J Infect Dis 167: 1100-1105.
31. Tucker JD, Li JZ, Robbins GK, Davis BT, Lobo AM, et al. (2011) Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sexually transmitted infections 87: 4-8.
32. Yang C, Latkin C, Luan RS, Wang CL, Nelson K, (2010) HIV, syphilis, hepatitis C and risk behaviours among commercial sex male clients in Sichuan province, China. Sexually transmitted infections 86: 559-564.
33. Marra CM, Sahi SK, Tantalo LC, Godornes C, Reid T, et al. (2010) Enhanced molecular typing of Treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis 202: 1380-1388.
34. Florindo C, Reigado V, Gomes J, Azevedo J, Santo I, et al. (2008) Molecular typing of Treponema pallidum clinical strains from Lisbon, Portugal. J Clin Microbiol 46: 3802-3803.
35. Tantalo LC, Lukehart SA, Marra CM, (2005) Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model. J Infect Dis 191: 75-80.
36. Peng RR, Wang AL, Li J, Tucker JD, Yin YP, et al. (2011) Molecular Typing of Treponema pallidum: A Systematic Review and Meta-Analysis. PLoS neglected tropical diseases 5: 1273-1276.
37. Peng RR, Yin YP, Wei WH, Wang HC, Zhu BY, et al. (2012) Molecular typing of Treponema pallidum causing early syphilis in China: a cross-sectional study. Sex Transm Dis 39: 42-45.
38. Martin IE, Gu W, Yang Y, Tsang RSW, (2009) Macrolide resistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin Infect Dis 49: 515-521.